Physician profile
Hal Brooks Hooper
NPI 1497906424
$5,073.27
in general payments reported to CMS, 2019-2025
43 companies · $1,068 in 2025
The $1,068 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $686 · 2021: $433 · 2022: $820 · 2023: $738 · 2024: $715 · 2025: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975 · Travel and Lodging: $501 · Education: $45.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.58 |
| Travel and Lodging | $500.86 |
| Education | $45.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $628.93 | 2019-2023 | Xiaflex, Aveed, Edex |
| Angiodynamics, INC. | $530.83 | 2025 | Nanoknife |
| Pfizer INC. | $477.70 | 2019-2025 | |
| Janssen Biotech, INC. | $472.03 | 2019-2025 | Erleada |
| Abbvie INC. | $455.20 | 2019-2024 | |
| Astellas Pharma US INC | $411.30 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Medtronic, INC. | $214.13 | 2022-2025 | Interstim |
| Urogen Pharma, INC. | $164.62 | 2020-2024 | Jelmyto |
| Sumitomo Pharma America, INC. | $164.14 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $136.99 | 2020-2024 | |
| Neotract INC. | $133.52 | 2019-2020 | |
| Boston Scientific Corporation | $97.17 | 2019-2024 | Lithovue, Rezum Generator |
| Merck Sharp & Dohme LLC | $93.58 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Dendreon Pharmaceuticals LLC | $74.30 | 2019-2025 | Provenge |
| Endo USA, INC. | $71.84 | 2024-2025 | Xiaflex, Aveed |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Hooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.